(aqi -HBc) were introduced into a routine testing programme for evidence of hepatitis B virus infection. Samples tested for anti-HBc were selected on the basis of the results of tests for HBsAg and clinical details. The sensitivity and specificity of the test were assessed and correlations made with the presence of HBsAg.
The presence of anti-HBc was very useful in the interpretation of a doubtful positive result for HBsAg in the haemagglutination test. With very few exceptions the serum samples positive for HBsAg by routine tests also contained anti-HBc.
It is concluded that the test is valuable and merits introduction into routine testing programmes.
It has been suggested (Cohen and Cossart, 1977) Received for publication 13 February 1978 samples were found to be positive for HBsAg (Table 1) . (Milne and Barr, 1971) Cohen and Cossart (1977) .
Results
The results of tests for anti-HBc on 255 serum samples are shown in Table 1 . HBsAg was present in 88 samples, and 87 of these also contained anti-HBc. The single HBsAg positive/anti-HBc negative patient was a blood donor known to have been free of HBsAg six months previously; a later sample of serum has been shown to contain anti-HBc, and the donor has developed hepatitis. There was one patient in group A who was HBsAg negative/anti-HBc positive; her brother was also found to be HBsAg negative/anti-HBc positive, and a past history of hepatitis was obtained from both.
Serum samples containing HBsAg from 82 patients were titrated using the Hepatest method and were also tested for HBsAg by IEM and CIEP. Anti-HBc was present in 81 of these samples and seemed to be unrelated to the HBsAg turkey erythrocyte haemagglutination titre (Table 2 ). AntiHBc was easily detected in the serum of two patients who were positive for HBsAg by the RIA test only. The single patient who was positive for HBsAg but lacked anti-HBc was the blood donor, previously mentioned, who subsequently developed hepatitis. In this group, two specimens with high haemagglutination titres (> 1/4096) were originally negative for HBsAg by CIEP; when re-tested at a dilution of 1/10 both showed a positive result.
The presence of anti-HBs was correlated with the presence of anti-HBc, and Table 4 shows that anti-HBc was detectable for at least three months after birth. One child, in whom samples were obtained at 2 months and 8 months, was positive for anti-HBc at 2 months, but in the 8-month sample anti-HBc could no longer be detected. sensitive, specific, and technically acceptable. CIEP has been used by more than one group of workers to detect anti-HBc (Budkowska et al., 1974; Cohen and Cossart, 1977) , and initial reports have been encouraging. While more sensitive methods, for instance, immune-adherence-haemagglutination (Tsuda et al., 1975) , radioimmunoprecipitation (Moritsugu et al., 1975) , and solid phase radioimmunoassay (Purcell et al., 1974) , have been developed to detect anti-HBc, CIEP offers a simple and practical technique for routine work, provided the results are useful in the diagnosis or prognosis of hepatitis B virus infection. At present the only serious limitation of CIEP for detecting anti-HBc is that suitable antigen is in short supply. Cohen and Cossart (1977) , using CIEP, showed that in 59 cases of acute hepatitis B, anti-HBc was invariably present as well as HBsAg. Similarly, they found that all 20 samples from patients suffering from HBsAg positive chronic hepatitis contained anti-HBc. Their study did not include any asymptomatic carriers of HBsAg, whereas this series includes 42 specimens from such patients ( Table 1) . The results presented here confirm and extend those of Cohen and Cossart, and show that if a serum sample contains HBsAg, whether the sample is from a patient suffering from acute hepatitis or from an asymptomatic chronic carrier of HBsAg, anti-HBc is almost always also present. Two exceptions to this statement may be noted. First, one of the patients listed in Table 1 (group B), and again in Table 2 , did not have antiHBc in his serum although the sample contained very large amounts of HBsAg. This patient appears to have been tested originally in the incubation period of hepatitis B virus infection, and the resulhant discrepancy (HBsAg+/anti-HBc-) is that described by Hoofnagle et al. (1975) as typical of this stage of the disease. A repeat sample taken after an interval of two weeks was shown to contain antiHBc as well as confirming the presence of HBsAg. Coincident with this second sample the patient developed hepatitis. The second situation in which anti-HBc may be absent despite the presence of HBsAg is in the severely immunosuppressed patient (Cohen and Cossart, 1977) . Our series contains no such patient, but the possibility of this finding must always be remembered.
As shown in Table 2 , the test for anti-HBc is just as reliably positive in the presence of very small or very large amounts of HBsAg. It should be noted that the CIEP test for HBsAg can occasionally be negative using neat serum when the amount of HBsAg is very large, although re-testing at a serum dilution of 1/10 produces a satisfactory positive result. In our experience, this problem has not occurred with CIEP for anti-HBc, and in such sera the positive CIEP test for anti-HBc has confirmed the positive haemagglutination test result and led to the challenging of the negative result for HBsAg by CIEP.
It appears that CIEP for anti-HBc is a sensitive technique, which may be used for the confirmation of the presence of HBsAg given the provisos mentioned earlier. The absence of anti-HBc in a sample thought to contain HBsAg should lead to reexamination of all the findings. Cohen and Cossart (1977) showed that anti-HBc could be found in the absence of HBsAg but that when this occurred anti-HBs was often also present, indicating past infection with hepatitis B virus.Our findings confirm that in the few patients found during routine testing to possess anti-HBs, anti-HBc may also be present (Table 3a) , and also show that anti-HBs is not necessarily accompanied by anti-HBc. Since anti-HBs is thought to decline in titre with the passage of time, and to persist longer than anti-HBc (Hoofnagle et al., 1975) , it would be logical to expect anti-HBc to be associated with high-titre antiHBs more often than low-titre anti-HBs. This expectation is supported by the results in Table 3a , which show that sera with high titres of anti-HBs also contain anti-HBc, whereas sera with low titres of anti-HBs have no detectable anti-HBc. This series also contains 20 samples collected from patients with a documented history of hepatitis B virus infection confirmed by the detection of HBsAg at the time, but in whom anti-HBs was not detected; the results of tests for anti-HBc on these specimens are shown in Table 3b . Anti-HBc was detected in all cases-in four samples more than three years after the acute attack. As 10 of the samples tested were obtained within six months of the acute illness antiHBs may still appear. Our test for the detection of anti-HBs (PHAI) is not as sensitive as the RIA method used by Cohen and Cossart, and some of the sera listed in Table 3b may contain anti-HBs at a low titre (< 1/4 by PHAI). These findings are difficult to interpret without a more sensitive test for anti-HBs but it seems that anti-HBc is a better indicator of fairly recent hepatitis B infection than anti-HBs.
Cohen and Cossart also found that certain patients, usually those with HBsAg negative acute hepatitis, produced antibodies which reacted with the HBcAg preparation in CIEP tests but which they showed by other methods to be non-specific. In some cases a reaction could also be obtained with a 'normal' liver extract. Group A (Table 1) includes sera from 17 patients suffering from acute hepatitis. These 17 samples were negative for HBsAg by RIA, and in 15 anti-HBc was not detected. However, in the remaining two samples a precipitin line appeared in the gel, which was different in appearance, size, and situation from the type of line we associate with anti-HBc. We were unable to follow the procedure adopted by Cohen and Cossart (1977) whereby the gel line was excised and shown by electron microscopy to contain aggregated HBcAg particles in truly positive reactions, but in the two cases mentioned above the reaction was so different from the line usually found that no confusion was produced.
No non-specific reactions to the core antigen were seen in the 63 samples from blood donors whose donations may have been associated with posttransfusion hepatitis; all 63 samples were negative for HBsAg by RIA and for anti-HBc by CIEP. The CIEP test for anti-HBc appears to be specific and useful for diagnostic purposes, provided an accurate medical history of the patient is available.
The technique for detecting anti-HBc by CIEP is familiar to many laboratories, especially those carrying out tests for HBsAg. Moreover, the method is rapid and economical and can be used to detect both HBsAg and anti-HBc. Serum samples giving inconclusive results in haemagglutination tests for HBsAg (group A, Table 1 ) cause a problem in laboratories lacking facilities for RIA. One possible solution to this situation is the recent introduction of enzyme-linked immunosorbent assay (ELISA) tests, which are stated to have a sensitivity for HBsAg approaching that of RIA (Wolters et al., 1976) . However, ELISA tests take several hours to perform and are relatively expensive, whereas CIEP for anti-HBc is quick and economical, and the results on 74 sera in group A (Table 1) show that failure to detect antiHBc helped to confirm the absence of HBsAg.
Anti-HBc tests were positive on sera from the five infants (Table 4) born to mothers whose sera in late pregnancy contained anti-HBc; these mothers were either chronic HBsAg carriers or had suffered from hepatitis B infection in the pregnancy. It seems likely that anti-HBc crosses into the fetal circulation as a maternal antibody and slowly disappears; in a 2-month-old infant the positive anti-HBc test had become negative six months later. 
